TrialJournal for immunotherapy of cancer2019

Circulating tumor cells in advanced non-small cell lung cancer patients are associated with worse tumor response to checkpoint inhibitors.

Menno Tamminga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.